RETACRIT is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Vifor (international) Inc.. The primary component is Erythropoietin.
| Product ID | 59353-002_3adf0922-a716-4bad-88b6-983a2e259a44 |
| NDC | 59353-002 |
| Product Type | Human Prescription Drug |
| Proprietary Name | RETACRIT |
| Generic Name | Epoetin Alfa-epbx |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2018-06-18 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125545 |
| Labeler Name | Vifor (International) Inc. |
| Substance Name | ERYTHROPOIETIN |
| Active Ingredient Strength | 2000 [iU]/mL |
| Pharm Classes | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [CS],Increased Erythroid Cell Production [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2018-06-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125545 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-06-18 |
| Marketing Category | BLA |
| Application Number | BLA125545 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2018-06-18 |
| Ingredient | Strength |
|---|---|
| ERYTHROPOIETIN | 2000 [iU]/mL |
| SPL SET ID: | e6e4dd0c-25ca-40b2-ba6b-6138a68621fe |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0069-1305 | RETACRIT | epoetin alfa-epbx |
| 0069-1306 | RETACRIT | epoetin alfa-epbx |
| 0069-1307 | RETACRIT | epoetin alfa-epbx |
| 0069-1308 | RETACRIT | epoetin alfa-epbx |
| 0069-1309 | RETACRIT | epoetin alfa-epbx |
| 0069-1311 | RETACRIT | epoetin alfa-epbx |
| 0069-1318 | RETACRIT | epoetin alfa-epbx |
| 59353-004 | RETACRIT | RETACRIT |
| 59353-002 | RETACRIT | RETACRIT |
| 59353-003 | RETACRIT | RETACRIT |
| 59353-010 | RETACRIT | RETACRIT |
| 59353-120 | RETACRIT | RETACRIT |
| 59353-220 | RETACRIT | RETACRIT |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RETACRIT 87340145 5770173 Live/Registered |
Hospira, Inc. 2017-02-17 |
![]() RETACRIT 85028565 3925022 Dead/Cancelled |
Hospira, Inc. 2010-05-03 |
![]() RETACRIT 77117569 not registered Dead/Abandoned |
Hospira, Inc. 2007-02-27 |